Status:
COMPLETED
Evaluation of the Intubating Laryngeal Airway in Children
Lead Sponsor:
University of British Columbia
Conditions:
Device - Intubating Laryngeal Airway
Eligibility:
All Genders
Up to 18 years
Brief Summary
The Air-Q® intubating laryngeal airway (Air-Q® ILA) is an extraglottic device specifically engineered for use both as a standalone laryngeal mask airway (LMA) and as a rescue device or "Plan B" device...
Detailed Description
Hypothesis: The Air-Q® intubating laryngeal airway (Air-Q® ILA) will act as an excellent conduit for fibreoptic intubation. Background: The laryngeal mask airway (LMA) is used during pediatric anesth...
Eligibility Criteria
Inclusion
- ASA I-III
- Ideal body weight as determined from weight/height centile curves (\>3rd \& \<97th centiles). Wei
- Elective surgery
- Appropriate subject and procedure for airway management by endotracheal intubation.
Exclusion
- ASA status IV-V
- Emergency surgery
- Anticipated difficult intubation
- Contraindication to LMA placement
- Aspiration risk; gastro-esophageal reflux disease
- Clinically significant pulmonary disease
- Coagulopathy
- Distorted airway anatomy judged likely to compromise LMA placement
- Allergy to any LMA components
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01233011
Start Date
December 1 2010
End Date
February 1 2015
Last Update
June 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
British Columbia Children's Hospital, Department of Anesthesia
Vancouver, British Columbia, Canada, V6H 3V4